Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination
Viruses expressing tumour antigens can prime and boost anti-tumour immunity but the efficiency of this approach depends on the capacity of the virus to infect the host. Here, the authors show that vaccination with oncolytic viruses co-administered with tumour antigenic peptides is as efficient as an...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/0087d0d0e932497c868d4c3d99452a6d |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|